FDA Grants Conditional Approval To First Antibody Drug Conjugate From ImmunoGen For Pretreated Ovarian Cancer

By: via Benzinga
TheFDA granted accelerated approvalforImmunoGen Inc's(NASDAQ: IMGN) Elahere (mirvetuximab ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.